Preliminary results of a phase II study of weekly paclitaxel (PTX) and carboplatin (CBDCA) administered concurrently with thoracic radiation therapy (TRT) followed by consolidation chemotherapy with PTX/CBDCA for stage III unresectable non-small-cell lung cancer (NSCLC).

Kaplan B., Altýnbas M., Eroglu C., Karahacioglu E., Er O., Ozkan M., ...Daha Fazla

American journal of clinical oncology, cilt.27, sa.6, ss.603-10, 2004 (SCI-Expanded, Scopus)